10.72 USD
↘ 0.24 (2.19%)AT CLOSE (11:59 AM EDT)
Fennec Pharmaceuticals Inc. Common Stock
FENCNASDAQ • USD
10.73
↗ 0.01 (0.09%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
10.73
↗ 0.01 (0.09%)
Market: CLOSED
Fennec Pharmaceuticals Inc. Common Stock (FENC) is currently trading at $10.70. There is a divergence between signals — underlying fundamentals rate "Buy" but technical indicators lean "Sell". Notable factors include a robust Altman Z-Score, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics place FENC at a fair price relative to peers.
Technical & fundamental data as of Sep 14, 2026.
Open?$10.94
High?$11.11
Low?$10.68
Prev. Close?$10.96
Volume?186.0K
Avg. Volume?252.4K
VWAP?$10.88
Rel. Volume?0.74x
Bid / Ask
Bid?$7.63 × 100
Ask?$13.09 × 100
Spread?$5.46
Midpoint?$10.36
Valuation & Ratios
Market Cap?384.3M
Shares Out?35.1M
Float?22.4M
Float %?64.2%
P/E Ratio?N/A
P/B Ratio?9.06
EPS?-$0.09
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Employees
35
Market Cap
384.3M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2002-01-28
Address
PO BOX 13628
RESEARCH TRIANGLE PARK, NC 27709
Phone: (919) 636-4530
RESEARCH TRIANGLE PARK, NC 27709
Phone: (919) 636-4530
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?77
Z-Score?95
Momentum?90
Short Sent.?84
Piotroski F-Score?6/9Mixed
Altman Z-Score?4.41Safe
Confidence?74%Moderate
Short InterestLow
Short % of Float?2.32%Low
Short Interest?520.7K
Days to Cover?2.0
Free Float22.4M
Avg Daily Volume255.9K
Settlement Date2026-08-31
Financial Health
Current Ratio?5.85Strong
Quick Ratio?5.66Strong
Cash Ratio?3.33Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?9.06HIGH▾
Peers100
S&P21
P/S?6.49FAIR▾
Peers100
S&P19
P/FCF?N/A▾
EV/EBITDA?-305.0CHEAP▾
S&P97
EV/Sales?5.79FAIR▾
Peers100
S&P29
Returns & Efficiency
ROE?-7.7%WEAK▾
S&P10
ROA?-4.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-2040000
Enterprise Value?$343.1M
Fundamentals ratios updated end of day